FDA Adverse Event Malfunction Summary report: N

COBAS E411 RACK SYSTEM

MDR report key: 2990813 · Received March 5, 2013

Report

Report Number
1823260-2013-01316
Event Type
Malfunction
Date Received
March 5, 2013
Date of Event
January 28, 2013
Report Date
March 13, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K961481
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION DETERMINED THE INTERFERENCE WAS NOT TO ANTI- STREPTAVIDIN ANTIBODIES. THE SAMPLE INTERFERENCE LEAD TO NON-LINEAR DILUTION BEHAVIOR IN THE ESTRADIOL REAGENT. THE INTERFERENCE CAN BE REMOVED WITH PEG PRECIPITATION. IT WAS A MACROMOLECULAR INTERFERENCE TYPE, THE EXACT TYPE COULD NOT BE DETERMINED. THERE WAS NO MORE SAMPLE AVAILABLE FOR INVESTIGATION.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER ALLEGED THEY RECEIVED QUESTIONABLE ESTRADIOL RESULTS FOR ONE PATIENT ON THEIR E411 ANALYZER. THE PATIENT'S INITIAL ESTRADIOL RESULT WAS 778.0 PG/ML. THE SAMPLE WAS DILUTED 1:2 AND THE RESULT WAS 533.4 PG/ML. ON 02/01/2013, THE PATIENT HAD A NEW SAMPLE MEASURED AND THE RESULT WAS >4300 PG/ML. THE SAMPLE WAS REPEATED AND THE RESULT WAS 4246 PG/ML. THE SAMPLE WAS THEN DILUTED 1:2 AND THE RESULT WAS 2634 PG/ML. THE SAMPLE WAS THEN DILUTED 1:5 AND THE RESULT WAS 2137 PG/ML. IT WAS UNKNOWN IF ANY OF THE RESULTS WERE REPORTED OUTSIDE THE LABORATORY. THERE WERE NO REPORTS OF ANY ADVERSE EVENTS. THE ESTRADIOL REAGENT LOT NUMBER WAS 167224 AND THE EXPIRATION DATE WAS 05/30/2013. THREE PATIENT SAMPLES WERE RETURNED FOR INVESTIGATION. THE RESULTS WERE NOT SUFFICIENT TO ASSESS THE INTERFERENCE, BUT THE GENERAL PRESENCE OF AN INTERFERING FACTOR IN THE PATIENT SAMPLE WAS CONFIRMED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
93589 COBAS E411 RACK SYSTEM IMMUNOCHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1 031 YR GONAPYRE INJECTION| CLOMID (CLOMIFENE CITRATE)